An artificial pancreas tested for the first time in a diabetic
A diabetic living in Montpellier has been one of the first two patients to test a portable insulin pump system. This "artificial pancreas" allowed him to go about his business without having to worry about his treatment.
Insulin bites could become a distant memory for many diabetics. This is at least what suggests a totally new experience performed in a Montpellier patient. This 58-year-old diabetic was the first in France to test the invention presented at a conference dedicated to diabetes technologies, held from October 27 to 29 in San Francisco. As a sort of "artificial pancreas", it allowed him to go to the restaurant, sleep at the hotel and spend a morning without having to worry about his treatment, while his life was previously dictated by measures. his blood glucose level and a permanent insulin supply, reports Le Point.
Concretely, the invention is a portable insulin pump system that is capable of self-regulation. For this, a measuring device placed under the skin continuously raises the glucose concentrations and communicates the results to a computer control system installed in a smartphone. Based on this data, the patient then sends the pump the amount of insulin it has to administer to maintain blood glucose levels at the proper levels. The device eliminates the need for multiple blood tests, insulin injections and thus alleviates the daily burden associated with diabetes management, says Health Log.
Last year, Cambridge University physicians reported in the medical journal The Lancet that they had successfully tested an automated insulin delivery device in about 20 children and adolescents with diabetes who had fifty nights in the hospital for the purposes of experimentation. Nevertheless, "the main innovative element of our system compared to the one tested in Cambridge is the miniaturization of the control module of the pump according to the glycemic level. Until then, experiments were not done outside the hospital. Another progress, the system that has just been tested in France operates automatically, without the need for human intervention. Our device therefore allows great physical freedom and could we say 'cerebral', comments Professor Eric Renard, a doctor at the Clinical Investigation Center INSERM-CHU Montpellier.
More tests to come
Parallel to this experiment, a second patient living this time in Padova in Italy was also briefly installed the device. But in view of the results, the trials will continue and will concern over the next weeks eight additional patients in Montpellier and Padua, before the duration of study in everyday life is extended over several days, and then over several weeks if the first successes are confirmed.